Marvao Medical specializes in the development, manufacturing and marketing of innovative medical devices to address unmet clinical needs and deliver high quality of care to the patient population.

Marvao Medical’s NexSitetm technology aims to manage the exit sites of Central Venous Catheters by promoting the formation of a biological seal around the catheter. This seal is intended to create a natural barrier around the catheter exit site.

  • News

    Marvao Medical Commences Its First Clinical Study

    Monday, 11 April, 2011: Marvao Medical, a Galway-based medical device company commenced its First in Man clinical study of its NexSite vascular access catheter in University Hospital Galway in late March, and enrolled their first patient on April 8, 2011. Catheters equipped with NexSite technology enable the patient’s skin to fully heal into the device...

    Marvao Medical Secures Investment

    February 9th 2011: Marvao Medical Devices, an early stage lrish medical device company focused on commercializing new central venous catheters, has secured investment of €1.3 million in a funding round led by the AIB Seed Capital Fund along with earlier private investors including Harmac Medical Products and the Western Development Commission. Marvao Medical will use...
  • NextSite CVC
  • ESM

    Exit Site Management, or ESM.

  • NexSitetm

    A technology that allows tissue to grow into a long-term percutaneous device creating a natural seal.